Arcellx’s $115 Million Series C Financing

Wilson Sonsini Goodrich & Rosati advised Arcellx on the deal.Arcellx, a privately held clinical-stage biopharmaceutical company, announced that it raised $115 million in a Series C…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here